Bipolar Disorder Clinical Trials

A listing of Bipolar Disorder medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 71 clinical trials
Culturally Adapted Psychoeducation for Bipolar Disorder in a Low-resource Setting: A Randomized Controlled Trial (CaPE)

Study objectives: To determine the effectiveness of the CaPE intervention compared to treatment as usual (TAU) in reducing the time to recurrence for people with bipolar disorder

  • 0 views
  • 16 Oct, 2022
  • 1 location
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Disorder: A Randomized, Double-blind, Midazolam-controlled, Phase II Clinical Trial (KET-BD)

ongoing randomized control trials (RCTs) have evaluated the effects of repeated doses of IV ketamine for a homogenous sample of patients with treatment-resistant bipolar disorder (TRBD). The primary

  • 0 views
  • 19 Oct, 2022
  • 1 location
A Randomized, Stratified, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of JNJ-55308942 in Bipolar Depression

The purpose of this study is to evaluate the efficacy of JNJ-55308942 compared to placebo on symptoms of depression in participants with bipolar disorder (BD) in a major depressive episode (MDE

depressed mood
body mass index
depression
depressive symptoms
  • 5 views
  • 23 Oct, 2022
  • 16 locations
Effectiveness RCT of Customized Adherence Enhancement (CAE-E)

Approximately one in two individuals with bipolar disorder (BD) are non-adherent with medication, often leading to severe and negative consequences. Unfortunately, there is no widely used

structured clinical interview
scid
lithium
mood stabilizer
  • 0 views
  • 10 Oct, 2022
  • 2 locations
Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep Apnea (QOSA)

Quetiapine is medication used to treat schizophrenia and bipolar disorder. Increasingly, low doses of quetiapine are prescribed "off-label" for insomnia. Quetiapine increases sleep duration with

  • 0 views
  • 07 Oct, 2022
  • 1 location
Immuno-Genetic, Inflammation, Retro-Virus, Environment (I-Give)

molecular and cellular targets. As Bipolar Disorder and Schizophrenia are now known to be significantly associated with neuro-inflammation, the project I-GIVE will combine multidisciplinary approaches

bipolar disorder
schizophrenia
Accepts healthy volunteers
psychiatric disorder
psychosis
  • 52 views
  • 04 Oct, 2022
  • 5 locations
A Multi-region, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression)

A clinical trial to study the efficacy and safety of an investigational drug in people with major depressive episodes associated with with Bipolar I disorder (bipolar I depression) Participants

  • 20 views
  • 18 Oct, 2022
  • 48 locations
Chinese Longitudinal and Systematic Study of Bioplar Disorder (CLASS-BD)

Affective disorders (mainly including major depressive disorder and bipolar disorder) are common, chronic and highly disabling mental disorders, which lack of objective biological markers. It is

Accepts healthy volunteers
  • 0 views
  • 21 Oct, 2022
  • 1 location
Multi-factor Model Constraction for Early Warning and Diagnosis of MDD

Current research on the pathogenesis of depression shows that imbalanced inflammatory factors are closely related to Major Depressive Disorder(MDD). As reported, physical exercise, Ω-3 fatty acids, and sulforaphane can be complementary therapies for moderate-to-severe depression. In addition, imaging studies have found changes in the structure and functional connectivity of the …

depression
omega-3 fatty acids
depressed mood
depressive episode
Accepts healthy volunteers
  • 0 views
  • 07 Oct, 2022
  • 1 location
Study to Compare the Use of a Behavioral Health App Versus Care as Usual for 16-22 Year Olds With Depression

Randomized Controlled Trial comparing a coach-enhanced digital cognitive behavioral intervention (d-CBI) (RxWell) + treatment as usual (TAU) versus TAU alone for moderate depression as determined by Patient Health Questionnaire (PHQ-9) threshold as part of routine pediatric care. The study will be completed in pediatric practices with embedded behavioral therapists across …

behavior therapy
anxiety
depressed mood
  • 0 views
  • 04 Oct, 2022
  • 1 location